Skip to content
2000
Volume 25, Issue 10
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background

Thyroid hormone deficiencies can disrupt organ functions, significantly impacting the cardiovascular system. Recently, the effects of thyroid hormones on the heart have garnered increased attention. However, most studies are conducted on humans using clinical data, while cellular-level and experimental studies remain limited.

Objective

This study aimed to investigate the cardiovascular implications of hypothyroidism and evaluate the impact of caffeine on cardiac health in rats induced with hypothyroidism using propylthiouracil (PTU).

Methods

The study involved 60 rats divided into six groups. Group 1 served as the untreated control. Group 2 received PTU for two months to induce hypothyroidism. Group 3 received PTU for one month, followed by caffeine for one month. Group 4 received caffeine for two months. Group 5 received both PTU and caffeine simultaneously for two months. Group 6 received PTU for one month, followed by one month under normal conditions.

Results

During necropsy, normal thyroid glands were observed in Groups 1, 4, and 6, enlarged thyroids in Group 2, and smaller thyroids in Groups 3 and 5. Microscopic examination revealed varying thyroid histologies: Group 2 showed significant epithelial cell proliferation and absent colloid, while Groups 3, 5, and 6 had altered yet colloid-containing acini. Macroscopic inspection of hearts appeared normal across all groups. However, histopathological examination revealed significant hyperemia and microhemorrhages in Group 2, contrasting with normal findings in other groups. Immunohistochemical analysis indicated reduced cardiac troponin expression in Group 2, while other groups maintained prominent expression. Additionally, Group 2 displayed increased serum TSH levels and decreased T3 and T4 levels.

Conclusion

The findings suggest that administering caffeine alongside or after PTU treatment in rats with experimentally induced hypothyroidism may ameliorate thyroid and cardiac irregularities. This study indicates caffeine's potential in mitigating the adverse effects of hypothyroidism on thyroid and heart health.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303315657240819114052
2025-01-09
2025-08-14

  • From This Site

    /content/journals/emiddt/10.2174/0118715303315657240819114052
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SadlerG.P. ClarkO.H. Thyroid and parathyroid.Principles of Surgery7th ed SchwartzS.I. ShiresG.T. SpencerF.C. McGraw-Hill: New York199916611687
     [Google Scholar]
  2. RenB. ZhuY. A new perspective on thyroid hormones: Crosstalk with reproductive hormones in females.Int. J. Mol. Sci.2022235270810.3390/ijms23052708 35269847
     [Google Scholar]
  3. AokiY. BelinR.M. ClicknerR. JeffriesR. PhillipsL. MahaffeyK.R. Serum TSH and total T4 in the United States population and their association with participant characteristics: National health and nutrition examination survey (nhanes 1999-2002).Thyroid200717121211122310.1089/thy.2006.0235 18177256
     [Google Scholar]
  4. ChakerL. RazviS. BensenorI.M. AziziF. PearceE.N. PeetersR.P. Hypothyroidism.Nat. Rev. Dis. Primers2022813010.1038/s41572‑022‑00357‑7 35589725
     [Google Scholar]
  5. Gomberg-MaitlandM. FrishmanW.H. Thyroid hormone and cardiovascular disease.Am. Heart J.1998135218719610.1016/S0002‑8703(98)70081‑X 9489964
     [Google Scholar]
  6. CappolaA.R. LadensonP.W. Hypothyroidism and Atherosclerosis.J. Clin. Endocrinol. Metab.20038862438244410.1210/jc.2003‑030398 12788839
     [Google Scholar]
  7. BengelF.M. LehnertJ. IbrahimT. KleinC. BülowH.P. NekollaS.G. SchwaigerM. Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism: A noninvasive study using positron emission tomography and magnetic resonance imaging.Thyroid200313547147710.1089/105072503322021133 12855014
     [Google Scholar]
  8. KhanR. SikanderkhelS. GuiJ. AdeniyiA.R. O’DellK. EricksonM. MalpartidaJ. MuftiZ. KhanT. MuftiH. Al-AdwanS.A. AlvarezD. DavisJ. PendleyJ. PatelD. Thyroid and cardiovascular disease: A focused review on the impact of hyperthyroidism in heart failure.Cardiol. Res.2020112687510.14740/cr1034 32256913
     [Google Scholar]
  9. PaschouS.A. BletsaE. StampouloglouP.K. TsigkouV. ValatsouA. StefanakiK. KazakouP. SpartalisM. SpartalisE. OikonomouE. SiasosG. Thyroid disorders and cardiovascular manifestations: An update.Endocrine202275367268310.1007/s12020‑022‑02982‑4 35032315
     [Google Scholar]
  10. von HafeM. NevesJ.S. ValeC. Borges-CanhaM. Leite-MoreiraA. The impact of thyroid hormone dysfunction on ischemic heart disease.Endocr. Connect.201985R76R9010.1530/EC‑19‑0096 30959486
     [Google Scholar]
  11. HellströmL. WahrenbergH. ReynisdottirS. ArnerP. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.J. Clin. Endocrinol. Metab.199782115916610.1210/jcem.82.1.3664 8989252
     [Google Scholar]
  12. BakkerS.J.L. ter MaatenJ.C. Popp-SnijdersC. SlaetsJ.P. HeineR.J. GansR.O. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects.J. Clin. Endocrinol. Metab.20018631206121110.1210/jc.86.3.1206 11238510
     [Google Scholar]
  13. CachefoA. BoucherP. VidonC. DusserreE. DiraisonF. BeylotM. Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients.J. Clin. Endocrinol. Metab.200186115353535710.1210/jcem.86.11.7981 11701705
     [Google Scholar]
  14. MavromatiM. JornayvazF.R. Hypothyroidism-associated dyslipidemia: Potential molecular mechanisms leading to NAFLD.Int. J. Mol. Sci.202122231279710.3390/ijms222312797 34884625
     [Google Scholar]
  15. RadostitsO.M. GayC.C. HinchcliffK.W. ConstableP.D. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats.10th edLondonElsevier Saunders2007966994
     [Google Scholar]
  16. ZhangJ. LazarM.A. The mechanism of action of thyroid hormones.Annu. Rev. Physiol.200062143946610.1146/annurev.physiol.62.1.439 10845098
     [Google Scholar]
  17. BaxterJ.D. DillmannW.H. WestB.L. HuberR. FurlowJ.D. FletterickR.J. WebbP. AprilettiJ.W. ScanlanT.S. Selective modulation of thyroid hormone receptor action.J. Steroid Biochem. Mol. Biol.2001761-5314210.1016/S0960‑0760(01)00052‑8 11384861
     [Google Scholar]
  18. YenP.M. Physiological and molecular basis of thyroid hormone action.Physiol. Rev.20018131097114210.1152/physrev.2001.81.3.1097 11427693
     [Google Scholar]
  19. OsunaP.M. UdovcicM. SharmaM.D. Hypothyroidism and the heart.Methodist DeBakey Cardiovasc. J.2017132606310.14797/mdcj‑13‑2‑60 28740583
     [Google Scholar]
  20. YamakawaH. KatoT.S. NohJ.Y. YuasaS. KawamuraA. FukudaK. AizawaY. Thyroid hormone plays an important role in cardiac function: From bench to bedside.Front. Physiol.20211260693110.3389/fphys.2021.606931 34733168
     [Google Scholar]
  21. KleinI. OjamaaK. Thyroid hormone and the cardiovascular system.N. Engl. J. Med.2001344750150910.1056/NEJM200102153440707 11172193
     [Google Scholar]
  22. TayalB. GraffC. SelmerC. KragholmK.H. KihlstromM. NielsenJ.B. OlsenA.M.S. PietersenA.H. HolstA.G. SøgaardP. ChristiansenC.B. FaberJ. GislasonG.H. Torp-PedersenC. HansenS.M. Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: A cross-sectional study of primary healthcare subjects from Copenhagen.BMJ Open201996e02385410.1136/bmjopen‑2018‑023854 31229996
     [Google Scholar]
  23. BertaE. LengyelI. HalmiS. ZrínyiM. ErdeiA. HarangiM. PállD. NagyE.V. BodorM. Hypertension in thyroid disorders.Front. Endocrinol.20191048210.3389/fendo.2019.00482 31379748
     [Google Scholar]
  24. HigdonJ.V. FreiB. Coffee and health: A review of recent human research.Crit. Rev. Food Sci. Nutr.200646210112310.1080/10408390500400009 16507475
     [Google Scholar]
  25. dePaulaJ. FarahA. Caffeine consumption through coffee: Content in the beverage, metabolism, health benefits and risks.Beverages2019523710.3390/beverages5020037
     [Google Scholar]
  26. GrahamT.E. Caffeine and exercise.Sports Med.2001311178580710.2165/00007256‑200131110‑00002 11583104
     [Google Scholar]
  27. TurnbullD. RodricksJ.V. MarianoG.F. ChowdhuryF. Caffeine and cardiovascular health.Regul. Toxicol. Pharmacol.20178916518510.1016/j.yrtph.2017.07.025 28756014
     [Google Scholar]
  28. PaluskaS.A. Caffeine and exercise.Curr. Sports Med. Rep.20032421321910.1249/00149619‑200308000‑00008 12834577
     [Google Scholar]
  29. SilvaL.A. WoukJ. WeberV.M.R. MalfattiC.R.M. OsieckiR. Relation between diabetes mellitus, thyroid hormones and caffeine.J. Appl. Pharm. Sci.201770321221610.7324/JAPS.2017.70334
     [Google Scholar]
  30. CooperD.S. RivkeesS.A. Putting propylthiouracil in perspective.J. Clin. Endocrinol. Metab.20099461881188210.1210/jc.2009‑0850 19401361
     [Google Scholar]
  31. AbdiH. AmouzegarA. AziziF. Antithyroid drugs.Iran. J. Pharm. Res.201918Suppl. 111210.22037/ijpr.2020.112892.14005 32802086
     [Google Scholar]
  32. KırımE. The effects of propylthiouracil on Tc-99m MIBI uptake on the thyroid and the heart tissues at acute phase..Cukurova University, Medical Faculty, Master thesis2007
     [Google Scholar]
  33. MullurR. LiuY.Y. BrentG.A. Thyroid hormone regulation of metabolism.Physiol. Rev.201494235538210.1152/physrev.00030.2013 24692351
     [Google Scholar]
  34. VendittiP. MeoS.D. Thyroid hormone-induced oxidative stress.Cell. Mol. Life Sci.200663441443410.1007/s00018‑005‑5457‑9 16389448
     [Google Scholar]
  35. Cano-EuropaB. Franco-ColinM. Ortiz-ButronR. The relationship between thyroid states, oxidative stress and cellular damage.Oxidative Stress and Diseases.InTech2012
     [Google Scholar]
  36. WróblewskiM. WróblewskaJ. NuszkiewiczJ. PawłowskaM. WesołowskiR. WoźniakA. The role of selected trace elements in oxidoreductive homeostasis in patients with thyroid diseases.Int. J. Mol. Sci.2023245484010.3390/ijms24054840 36902266
     [Google Scholar]
  37. KalyanaramanB. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms.Redox Biol.20131124425710.1016/j.redox.2013.01.014 24024158
     [Google Scholar]
  38. PizzinoG. IrreraN. CucinottaM. PallioG. ManninoF. ArcoraciV. SquadritoF. AltavillaD. BittoA. Oxidative stress: Harms and benefits for human health.Oxid. Med. Cell. Longev.2017201711310.1155/2017/8416763 28819546
     [Google Scholar]
  39. MahzariM. AlserehiA. AlmutairiS. AlanaziK. AlharbiM. MohamudM. Hypothyroidism and the risk of coronary artery disease in Saudi patients.J. Family Community Med.2022291344010.4103/jfcm.jfcm_368_21 35197726
     [Google Scholar]
  40. BrathwaiteJ.M. Da CostaL.A. El-SohemyA. Catechol-o-methyltransferase genotype is associated with self-reported increased heart rate following caffeine consumption.J. Caffeine Res.20111212313010.1089/jcr.2011.0015
     [Google Scholar]
  41. UdovcicM. PenaR.H. PathamB. TabatabaiL. KansaraA. Hypothyroidism and the heart.Methodist DeBakey Cardiovasc. J.2017132555910.14797/mdcj‑13‑2‑55 28740582
     [Google Scholar]
  42. TribulovaN. KnezlV. ShainbergA. SekiS. SoukupT. Thyroid hormones and cardiac arrhythmias.Vascul. Pharmacol.2010523-410211210.1016/j.vph.2009.10.001 19850152
     [Google Scholar]
  43. PalmerS. KentishJ.C. The role of troponin C in modulating the Ca2+ sensitivity of mammalian skinned cardiac and skeletal muscle fibres.J. Physiol.19944801456010.1113/jphysiol.1994.sp020339 7853225
     [Google Scholar]
  44. CostantiniF. PierdomenicoS.D. CesareD.D. De RemigisP. BucciarelliT. Bittolo-BonG. CazzolatoG. NubileG. GuagnanoM.T. SensiS. CuccurulloF. MezzettiA. Effect of thyroid function on LDL oxidation.Arterioscler. Thromb. Vasc. Biol.199818573273710.1161/01.ATV.18.5.732 9598831
     [Google Scholar]
  45. VillanuevaI. Alva-SánchezC. Pacheco-RosadoJ. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration.Oxid. Med. Cell. Longev.2013201311510.1155/2013/218145 24386502
     [Google Scholar]
  46. BianchiG. SolaroliE. ZaccheroniV. GrossiG. BargossiA. MelchiondaN. MarchesiniG. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: Effect of treatment.Horm. Metab. Res.1999311162062410.1055/s‑2007‑978808 10598831
     [Google Scholar]
  47. KochmanJ. JakubczykK. BargielP. Janda-MilczarekK. The influence of oxidative stress on thyroid diseases.Antioxidants2021109144210.3390/antiox10091442 34573074
     [Google Scholar]
  48. ClozelM. BranchaudC.L. TannenbaumG.S. DussaultJ.H. ArandaJ.V. Effect of caffeine on thyroid and pituitary function in newborn rats.Pediatr. Res.198317759259510.1203/00006450‑198307000‑00015 6413944
     [Google Scholar]
  49. PietznerM. KöhrleJ. LehmphulI. BuddeK. KastenmüllerG. BrabantG. VölzkeH. ArtatiA. AdamskiJ. VölkerU. NauckM. FriedrichN. HomuthG. A thyroid hormone-independent molecular fingerprint of 3,5-diiodothyronine suggests a strong relationship with coffee metabolism in humans.Thyroid201929121743175410.1089/thy.2018.0549 31571530
     [Google Scholar]
  50. ZhengJ. ZhuX. XuG. WangX. CaoM. ZhuS. HuangR. ZhouY. Relationship between caffeine intake and thyroid function: Results from NHANES 2007–2012.Nutr. J.20232213610.1186/s12937‑023‑00866‑5 37491267
     [Google Scholar]
  51. LiuZ. GerdesA.M. Influence of hypothyroidism and the reversal of hypothyroidism on hemodynamics and cell size in the adult rat heart.J. Mol. Cell. Cardiol.199022121339134810.1016/0022‑2828(90)90979‑C 2089154
     [Google Scholar]
  52. GerdesA.M. OjamaaK. Thyroid hormone and cardioprotection.Compr. Physiol.2016631199121910.1002/cphy.c150012 27347890
     [Google Scholar]
  53. MontalvoD. Pérez-TreviñoP. Madrazo-AguirreK. González-MondelliniF.A. Miranda-RobleroH.O. Ramonfaur-GraciaD. Jacobo-AntonioM. Mayorga-LunaM. Gómez-VíquezN.L. GarcíaN. AltamiranoJ. Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism.Cell Calcium201872263810.1016/j.ceca.2018.01.005 29748131
     [Google Scholar]
  54. BengelF.M. NekollaS.G. IbrahimT. WenigerC. ZieglerS.I. SchwaigerM. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging.J. Clin. Endocrinol. Metab.20008551822182710.1210/jcem.85.5.6520 10843159
     [Google Scholar]
  55. DanziS. KleinI. Thyroid hormone and the cardiovascular system.Med. Clin. North Am.201296225726810.1016/j.mcna.2012.01.006 22443974
     [Google Scholar]
  56. DanziS. KleinI. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease.Thyroid200212646747210.1089/105072502760143836 12165108
     [Google Scholar]
  57. BouterS.L. DemolombeS. ChambellanA. BellocqC. AimondF. ToumaniantzG. LandeG. SiavoshianS. BaróI. PondA.L. NerbonneJ.M. LégerJ.J. EscandeD. CharpentierF. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: Relation to cellular and integrated electrophysiology.Circ. Res.200392223424210.1161/01.RES.0000053185.75505.8E 12574152
     [Google Scholar]
  58. BiondiB. PalmieriE.A. LombardiG. FazioS. Effects of thyroid hormone on cardiac function: The relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism.J. Clin. Endocrinol. Metab.200287396897410.1210/jcem.87.3.8302 11889145
     [Google Scholar]
  59. Carrillo-SepúlvedaM.A. CeravoloG.S. FortesZ.B. CarvalhoM.H. TostesR.C. LaurindoF.R. WebbR.C. Barreto-ChavesM.L.M. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.Cardiovasc. Res.201085356057010.1093/cvr/cvp304 19734167
     [Google Scholar]
  60. KahalyG.J. DillmannW.H. Thyroid hormone action in the heart.Endocr. Rev.200526570472810.1210/er.2003‑0033 15632316
     [Google Scholar]
  61. ZhangS. LiR. MaY. YanY. MaM. ZhangK. ZhouY. LiL. PanL. YingH. XueY. Thyroid‐stimulating hormone regulates cardiac function through modulating HCN2 via targeting MICRORNA ‐1a.FASEB J.20223610e2256110.1096/fj.202200574R 36125044
     [Google Scholar]
  62. KinugawaK. MinobeW.A. WoodW.M. RidgwayE.C. BaxterJ.D. RibeiroR.C.J. TawadrousM.F. LowesB.A. LongC.S. BristowM.R. Signaling pathways responsible for fetal gene induction in the failing human heart: Evidence for altered thyroid hormone receptor gene expression.Circulation200110381089109410.1161/01.CIR.103.8.1089 11222471
     [Google Scholar]
  63. RajagopalanV. GerdesA.M. Role of thyroid hormones in ventricular remodeling.Curr. Heart Fail. Rep.201512214114910.1007/s11897‑014‑0246‑0 25492377
     [Google Scholar]
  64. TangY.D. KuzmanJ.A. SaidS. AndersonB.E. WangX. GerdesA.M. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction.Circulation2005112203122313010.1161/CIRCULATIONAHA.105.572883 16275864
     [Google Scholar]
  65. BiondiB. Mechanisms in Endocrinology: Heart failure and thyroid dysfunction.Eur. J. Endocrinol.2012167560961810.1530/EJE‑12‑0627 22956554
     [Google Scholar]
  66. KissE. JakabG. KraniasE.G. EdesI. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.Circ. Res.199475224525110.1161/01.RES.75.2.245 8033338
     [Google Scholar]
  67. ShenoyR. KleinI. OjamaaK. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles.Am. J. Physiol. Heart Circ. Physiol.20012814H1690H169610.1152/ajpheart.2001.281.4.H1690 11557559
     [Google Scholar]
  68. CasisO. EcheazarraL. Sáenz-DíezB. GallegoM. Deciphering the roles of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism.J. Physiol. Biochem.20248011910.1007/s13105‑023‑01000‑z 38019451
     [Google Scholar]
  69. KimE.J. LyassA. WangN. MassaroJ.M. FoxC.S. BenjaminE.J. MagnaniJ.W. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham heart study).Am. Heart J.2014167112312610.1016/j.ahj.2013.10.012 24332151
     [Google Scholar]
  70. AweimerA. SchiedatF. SchöneD. Landgrafe-MendeG. BogossianH. MüggeA. PatsalisP.C. GotzmannM. AkinI. El-BattrawyI. DietrichJ.W. Abnormal cardiac repolarization in thyroid diseases: Results of an observational study.Front. Cardiovasc. Med.2021873851710.3389/fcvm.2021.738517 34888359
     [Google Scholar]
  71. AnS. GilaniN. HuangY. MuncanA. ZhangY. TangY.D. GerdesA.M. OjamaaK. Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment.Mol. Med.20192515310.1186/s10020‑019‑0120‑3 31810440
     [Google Scholar]
  72. FlynnR.W. BonellieS.R. JungR.T. MacDonaldT.M. MorrisA.D. LeeseG.P. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.J. Clin. Endocrinol. Metab.201095118619310.1210/jc.2009‑1625 19906785
     [Google Scholar]
  73. RodondiN. den ElzenW.P.J. BauerD.C. CappolaA.R. RazviS. WalshJ.P. ÅsvoldB.O. IervasiG. ImaizumiM. ColletT.H. BremnerA. MaisonneuveP. SgarbiJ.A. KhawK.T. VanderpumpM.P.J. NewmanA.B. CornuzJ. FranklynJ.A. WestendorpR.G.J. VittinghoffE. GusseklooJ. Thyroid studies collaboration, subclinical hypothyroidism and the risk of coronary heart disease and mortality.JAMA2010304121365137410.1001/jama.2010.1361 20858880
     [Google Scholar]
  74. ImaizumiM. AkahoshiM. IchimaruS. NakashimaE. HidaA. SodaM. UsaT. AshizawaK. YokoyamaN. MaedaR. NagatakiS. EguchiK. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism.J. Clin. Endocrinol. Metab.20048973365337010.1210/jc.2003‑031089 15240616
     [Google Scholar]
  75. YamakawaH. KatoT.S. NohJ.Y. YuasaS. KawamuraA. FukudaK. AizawaY. Thyroid hormone plays an ımportant role in cardiac function: From bench to bedside.Front. Physiol.20211260693110.3389/fphys.2021.606931 34733168
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303315657240819114052
Loading
Cardiovascular Findings and Effects of Caffeine on Experimental Hypothyroidism
Endocr Metab Immune Disord Drug Targets 25, 777 (2025); https://doi.org/10.2174/0118715303315657240819114052
/content/journals/emiddt/10.2174/0118715303315657240819114052
/content/journals/emiddt/10.2174/0118715303315657240819114052
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Caffeine; heart; hypothyroidism; immunohistochemistry; pathology; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test